The FDA is reviewing a possible link between the asthma drug Xolair and an increased risk of heart and cerebrovascular disorders.Since the FDA investigation is still under way, the agency is not telling doctors to stop prescribing Xolair and is not recommending any changes to the prescribing information for Xolair.
More...



Flanked by top health officials including Health Secretary Robert F. Kennedy Jr., President Trump unveiled a...
Respiratory therapist Marcy Freeman doesn't need a research study to confirm for her a return to...
Cases of cyclosporiasis, a parasitic infection known for causing explosive diarrhea, have now reached 47 states...





























